Zai Lab share price logo

Zai Lab

NASDAQ: ZLAB

Mid Cap

$25.78

-1.22

(-4.52%)

Live

as on

Zai Lab Stock Performance

as on September 5, 2026 at 1:12 am IST

  • Day's Low

    Day's High

    $25.46
    $26.49
    downward going graph

    1.24%

    Downside

    2.75%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $15.96
    $34.72
    downward going graph

    38.09%

    Downside

    34.68%

    Upside

    downward going graph

Zai Lab share price movements today

Previous Close
$27.00
Open
$26.49
Volume
114.4K
Market Cap
$3.0B
Day's Low - High
$25.46 - $26.49
52 Week Low - High
$15.96 - $34.72

Zai Lab Historical Returns

1 Month Return
+ 46.02 %
3 Month Return
+ 55.71 %
1 Year Return
-10 %
3 Year Return
+ 3.45 %
5 Year Return
-81.45 %

Zai Lab Stock Fundamentals & Key Indicators

Check Zai Lab market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0B

EPS (TTM)

-1.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.06

Industry PE ratio

-13.53

PEG Ratio

-0.18334983597832546

EBITDA

-168.8M

Revenue (TTM)

449.6M

Profit Margin

56.47%

Return On Equity TTM

-27.40%

Zai Lab Stock Valuation

Track how Zai Lab P/E has moved over time to understand its valuation trends.

Zai Lab in the last 5 years

  • Overview

  • Trends

Lowest (-11.03x)

December 31, 2025

Industry (-13.53x)

December 31, 2025

Today (-11.03x)

December 31, 2025

Highest (-0.66x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -11.03x

Zai Lab vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zai Lab with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$3.0B-81.45%-15.0656.47%NA
BUY$44.6B614.61%NA0.00%NA
BUY$141.1B181.73%32.2186.04%NA
BUY$60.2B-64.27%-18.66-12.57%NA
BUY$84.8B24.12%20.1484.86%0.44%

Stock Returns calculator for Zai Lab Stock including INR - Dollar returns

The Zai Lab stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Zai Lab investment value today

Current value as on today

₹92,064

Returns

-₹7,936

(-7.94%)

Returns from Zai Lab Stock

-₹14,067 (-14.07%)

Dollar Impact

₹6,131 (+6.13%)

Analyst Recommendation on Zai Lab Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Zai Lab. Average target price of $33.14

Zai Lab Share Price Target

Get share price movements and forecasts by analysts on Zai Lab.

What analysts predicted

22.21%UPSIDE

Target Price

$33.14

Current Price

$25.78

Analyzed by

3 Analysts

Target

$33.14

Zai Lab target price $33.14, a slight upside of 22.21% compared to current price of $25.78. According to 3 analysts rating.

Indian Investors' Interest in Zai Lab Stock

Search interest for Zai Lab Stock has increased by 163% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:163% versus previous 30 day period

Zai Lab Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
87
100
102
109
106
109
116
127
99
106
Gross Profit
53
65
65
66
67
66
69
65
61
58
Operating Income
-70
-76
-67
-67
-56
-54
-48
-69
-69
-76
EBITDA
-50
-76
-38
-75
-43
-35
-30
-48
-43
-46
Interest Expense
0
0
0
0
1
1
1
1
1
1
Depreciation
3
2
2
5
3
3
3
3
3
4
Income Before Tax
-53
-80
-41
-81
-48
-40
-35
-53
-49
-51
Income Tax Expense
-
-
-
-
-
-
-
-2
1
-1
Net Income
-53
-80
-41
-81
-48
-40
-35
-50
-51
-50
Net Profit Margin
61.42%
64.94%
63.90%
61.41%
63.71%
60.70%
59.62%
51.15%
61.52%
54.70%

Zai Lab Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
12
48
144
215
266
398
460
Gross Profit
-
0
9
-190
92
141
170
251
269
Operating Income
-51
-141
-203
-301
-700
-404
-366
-282
-223
EBITDA
-50
-138
-190
-297
-689
-434
-365
-234
-158
Interest Expense
-
0
0
0
-
-
-
2
5
Depreciation
0
1
3
4
6
8
9
20
15
Income Before Tax
-50
-138
-206
-268
-703
-443
-334
-257
-178
Income Tax Expense
0
3
-10
-
1
-
-
-
-2
Net Income
-50
-139
-195
-268
-704
-443
-334
-257
-175
Net Profit Margin
0.00%
66.33%
71.13%
-389.09%
63.80%
65.58%
64.08%
62.94%
58.47%

Zai Lab Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-53
-80
-41
-81
-48
-40
-35
-50
-51
-50
Operating Cash Flow
-90
-42
-26
-55
-61
-31
-32
-26
-11
-45
Investing Cash Flow
3
0
-29
-347
326
-2
-4
-11
-22
-1
Financing Cash Flow
47
22
42
237
43
8
20
0
5
18
Change in Cash
-39
-20
-13
-166
307
-24
-15
-37
-28
-43

Zai Lab Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-139
-195
-268
-704
-443
-334
-257
-175
Operating Cash Flow
-32
-97
-191
-216
-549
-367
-198
-214
-150
Investing Cash Flow
-10
-212
-14
-554
249
420
-10
-375
307
Financing Cash Flow
187
144
219
1,132
820
-1
-6
349
72
Change in Cash
145
-166
13
366
522
44
-218
-240
229

Mutual Funds that own Zai Lab Stock

Check out the Mutual Funds with significant holdings in Zai Lab.

Funds
Holdings
Shares Held
BARON SELECT FUNDS
1.288442%
1466026
Fidelity Investment Trust
0.954154%
1085664
Fidelity Mt. Vernon Street Trust
0.488074%
555345
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
0.187351%
213174
Brinker Capital Destinations Trust
0.06901%
78522

Global Institutional Holdings in Zai Lab

Funds
Holdings
Peter Kolchinsky
5.05%
Michael Rockefeller
1.94%
iShares
0.63%
Tema
0.14%
ALPS
0.13%

Zai Lab News & Key Events

  • img

    Today's Timeline - 06 August

    Thu, 04:11 PM

    -

    Zai Lab reports Q2 2026 revenue of $105.75M, net loss of $50.83M, and diluted EPS of ($0.05).

Insights on Zai Lab

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -51.01M → -50.82M (in $), with an average increase of 0.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 99.61M → 106.31M (in $), with an average increase of 6.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ZLAB stock has moved up by 46.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 513.1% return, outperforming this stock by 523.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 32.3% return, outperforming this stock by 28.9%

About Zai Lab

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.
OrganisationZai Lab
HeadquartersBuilding B, Pudong, China, 201203
IndustryBiotechnology
CEODr. Ying Du Ph.D.
E-voting on sharesClick here to vote

Key Management of Zai Lab

Name

Title

Dr. Ying Du Ph.D.

Founder, Chairperson & CEO

Dr. Rafael G. Amado M.D.

President and Head of Global Research & Development

Dr. Yajing Chen Ph.D.

Chief Financial Officer

Mr. Frazor Titus Edmondson III, J.D.

Chief Legal Officer & Corporate Secretary

Ms. Christine Chiou

Senior VP & Head of Investor Relations

Dr. James Yan DABT, M.D., Ph.D.

Chief Operating Officer of Global R&D

Dr. Shan He Ph.D.

Senior VP & Chief Business Officer

FAQs

What is Zai Lab share price today?

Zai Lab share price today is $25.78 as on . Zai Lab share today touched a day high of $26.49 and a low of $25.46.

What is the 52 week high and 52 week low for Zai Lab share?

Zai Lab share touched a 52 week high of $34.72 on and a 52 week low of $15.96 on . Zai Lab stock price today i.e. is trending at $25.78,which is 25.75% down from its 52 week high and 61.53% up from its 52 week low.

What is Zai Lab's market capitalisation today?

Zai Lab market capitalisation is $0.00T as on .

How to invest in Zai Lab Stock (ZLAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zai Lab on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zai Lab Shares that will get you 0.0582 shares as per Zai Lab share price of $25.78 per share as on September 4, 2026 at 7:42 pm IST.

What is the minimum amount required to buy Zai Lab Stock (ZLAB) from India?

Indian investors can start investing in Zai Lab (ZLAB) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Zai Lab stock (as per the Rupee-Dollar exchange rate as on ). Based on Zai Lab share’s latest price of $25.78 as on September 4, 2026 at 7:42 pm IST, you will get 0.3879 shares of Zai Lab. Learn more about fractional shares .

What are the returns that Zai Lab has given to Indian investors in the last 5 years?

Zai Lab stock has given -81.45% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?